Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD001 + Docetaxel in Recurrent NSCLC
NCT00406276Phase 2Terminated
- Sponsor
- Emory University
- Start
- Nov 2006
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in non-small cell lung cancer (NSCLC), sponsored by Emory University. Started Nov 2006; status: terminated.
02
Drugs
everolimus
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00406276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00406276.